Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Moodys
Queensland Health
Covington
Colorcon

Generated: June 20, 2019

DrugPatentWatch Database Preview

METYRAPONE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for metyrapone and what is the scope of metyrapone patent protection?

Metyrapone is the generic ingredient in one branded drug marketed by Laboratorie Hra and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for metyrapone. One supplier is listed for this compound.

Pharmacology for METYRAPONE
Medical Subject Heading (MeSH) Categories for METYRAPONE
Synonyms for METYRAPONE
054M364
1-Propanone, 1,2-di-3-pyridyl-2-methyl-
1-Propanone, 2-methyl-1,2-di-3-pyridinyl-
1-Propanone, 2-methyl-1,2-di-3-pyridyl-
1-Propanone,2-di-3-pyridinyl-
1-Propanone,2-di-3-pyridyl-
1,2-Di-3-pyridyl-2-methyl-1-propanone
2-methyl-1,2-bis(3-pyridinyl)-1-propanone
2-Methyl-1,2-bis(3-pyridyl)-1-propanone
2-methyl-1,2-bis(3-pyridyl)propan-1-one
2-methyl-1,2-bis(pyridin-3-yl)propan-1-one
2-Methyl-1,2-di-3-pyridinyl-1-propanone
2-Methyl-1,2-di-3-pyridyl-1-propanone
2-Methyl-1,2-di-3-pyridyl-1-propanone, 96%
2-Methyl-1,2-di(3-pyridinyl)-1-propanone #
2-methyl-1,2-di(3-pyridyl)propan-1-one
2-methyl-1,2-di(pyridin-3-yl)propan-1-one
2-methyl-1,2-dipyridin-3-yl-propan-1-one
2-methyl-1,2-dipyridin-3-ylpropan-1-one
37245-80-0
54-36-4
A830124
AB00513955
AB00513955_07
AC1L1HKV
AC1Q1LHX
AJ-08075
AKOS015919707
AN-41656
ANW-47874
API0003315
AX8140081
B7347
BCP19099
BDBM50028166
BG0427
BIDD:PXR0082
BPBio1_000824
BR-51541
BRD-K46862739-001-03-6
BSPBio_000748
C-12887
C07205
C14H14N2O
CAS-54-36-4
CC-30940
CCG-213598
CHEBI:44241
CHEMBL934
CPD000059134
CS-4879
CTK8B5187
D00410
DB01011
DSSTox_CID_3314
DSSTox_GSID_23314
DSSTox_RID_76971
DTXSID1023314
EINECS 200-206-2
EU-0009322
EX-A1403
FJLBFSROUSIWMA-UHFFFAOYSA-N
FT-0603230
GTPL5224
HMS1570F10
HMS2094I07
HMS2097F10
HMS2235E16
HMS3259O05
HMS3371B16
HMS3714F10
HSDB 2500
HY-B1232
I14-92873
KS-00001FBF
LS-123097
MCULE-7018205003
Mepyrapone
Metapirone
Metapyron
Metapyrone
Methapyrapone
Methbipyranone
Methopirapone
Methopyrapone
Methopyrinine
Methopyrone
Metirapona
Metirapona [INN-Spanish]
Metopiron
Metopirone
METOPIRONE (TN)
Metopyrone
Metroprione
Metyrapon
Metyrapone (JP17/USP/INN)
Metyrapone [USAN:INN:BAN:JAN]
Metyrapone [USAN:USP:INN:BAN:JAN]
Metyrapone, >=98% (HPLC), solid
Metyrapone, United States Pharmacopeia (USP) Reference Standard
Metyraponum
Metyraponum [INN-Latin]
MFCD00006397
MLS001066377
MLS001335881
MLS001335882
MolPort-001-794-644
MYT
NC00462
NCGC00016242-01
NCGC00016242-02
NCGC00016242-03
NCGC00016242-05
NCGC00161837-01
NSC 25265
NSC-25265
NSC-760076
NSC25265
NSC760076
Pharmakon1600-01506014
Prestwick0_000904
Prestwick1_000904
Prestwick2_000904
Prestwick3_000904
PubChem16052
S-6399
SAM002297829
SC-49180
SCHEMBL637432
SMR000059134
SPBio_002947
SR-01000765398
SR-01000765398-2
ST24028079
ST51006925
Su 4885
TC-136619
Tox21_110323
Tox21_110323_1
UNII-ZS9KD92H6V
W6860
ZB000400
ZINC1728
ZS9KD92H6V

US Patents and Regulatory Information for METYRAPONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Laboratorie Hra METOPIRONE metyrapone TABLET;ORAL 012911-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Laboratorie Hra METOPIRONE metyrapone CAPSULE;ORAL 012911-002 Aug 9, 1996 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
UBS
Covington
Harvard Business School
McKesson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.